her2

T-DXd is finally approved for marketing in China! How has it changed cancer treatment?
cancer breast cancer her2
03-07
Advances in her2-expressive breast cancer research
breast cancer her2
05-08
Distinguishing between BREAST CANCER HER2 0 and 1+ may require new tests
her2 breast cancer drugs
04-27
How can Puri Benchmark become a "new R&D partner" for pharmaceutical companies?
Pharmaceutical companies Puri benchmark breast cancer her2
04-15
How are patients with her2-positive breast cancer brain metastases treated? The official ESMO paper is for you
her2 Breast cancer brain metastases masculine breast cancer Brain metastases Random
03-21
【Medical companion travel】The risk of brain metastasis progression is reduced by 68%, and the new pattern of breast cancer treatment of Monte Everest tucatanib in Bangladesh is new
Tukatinib breast cancer Brain metastases Medical companion travel her2
02-21
Annual Inventory: Clinical Progress and Future Trends in Breast Cancer
breast cancer clinic Endocrine therapy chemotherapy her2 ds-8201 olympia parpi The Big Three Liu Shu
01-25
After entering the melee, how do ADC companies strategically layout, and see how the world's leading first and third totals are doing?
First three totals drugs her2 Non-small cell lung cancer breast cancer
01-19
2022 NCN Guidelines for Lung Cancer: Rare Mutations Have New Targeted Drug Recommendations
lung cancer NCCN Guidelines Targeted drugs her2 breast cancer nsclc
01-09
China's first ADC for the treatment of urinary urothelial cancer is coming! Rongchang Bio vidicetizumab new indications were approved for listing
Vidicetizumab Urinary tract carcinoma Rongchang Biology State Food and Drug Administration of China her2
01-06
Eli Lilly breast cancer new drug adds indications for early-stage breast cancer
breast cancer Early breast cancer Abésili Eli Lilly her2
01-06
To save more stomach cancer patients, the results of the new 3-link anti-cancer therapy are released, and the effect is optimistic
gastric cancer anticancer her2 cancer
12-16